Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

KIDS.US Logo

KIDS.US - Current Price

$20.11

Company Information

▼
Company Name
Orthopediatrics Corp
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US68752L1008
CIK: 0001425450
CUSIP: 68752L100
Currency: USD
Full Time Employees: 562
Phone: 574 268 6379
Website: https://www.orthopediatrics.com
Fiscal Year End: December
IPO Date: Oct 12, 2017
Description:

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Address:

2850 Frontier Drive, Warsaw, IN, United States, 46582

Directors & Officers

▼
Name Title Year Born
Mr. Mark C. Throdahl Executive Chairman 1951
Mr. David R. Bailey President, CEO & Director 1979
Mr. Fred L. Hite CFO, Principal Financial & Accounting Officer, COO and Director 1968
Mr. Daniel J. Gerritzen J.D. Executive VP of Legal, General Counsel & Secretary 1970
Mr. Gregory A. Odle President of Scoliosis 1970
Mr. Joseph W. Hauser President of Trauma, Deformity Correction & OPSB 1982
Mr. Kevin L. Unger CHE, MBA/MSHA President of Enabling Technologies 1972
Mr. Mark Karshner Senior Vice President of International Sales NA
Ray Garrison Senior Vice President of Quality & Regulatory and Clinical NA

Shares Statistics

▼
Shares Outstanding: 25.08M
Shares Float: 15.48M
% Insiders: 3,271.50%
% Institutions: 7,091.10%
Short % Float: 6.35%

Valuation Metrics

▼
Enterprise Value: $500.78M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $504.31M
EBITDA: $-12.55M
Book Value: $13.93
Earnings/Share: $-1.96
Profit Margin: -20.06%
Operating Margin: -7.94%
ROA (TTM): -4.08%
ROE (TTM): -12.67%
Revenue (TTM): $227.41M
Revenue/Share (TTM): $9.74
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 12.20%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -0.24 -0.25 N/A 287.33%
Jun 30, 2025 -0.11 -0.29 N/A 6,206.90%
Mar 31, 2025 -0.39 -0.44 N/A 1,034.48%
Dec 31, 2024 -0.29 -0.26 N/A -1,297.23%
Sep 30, 2024 -0.34 -0.24 N/A -4,166.67%
Jun 30, 2024 -0.26 -0.27 N/A 370.37%
Mar 31, 2024 -0.34 -0.40 N/A 1,500.00%
Dec 31, 2023 -0.29 -0.28 N/A -357.14%
Sep 30, 2023 -0.20 -0.23 N/A 1,304.35%
Jun 30, 2023 -0.13 -0.22 N/A 4,090.91%
Mar 31, 2023 -0.30 -0.36 N/A 1,666.67%
Dec 31, 2022 -0.35 -0.25 N/A -4,000.00%
Sep 30, 2022 -0.07 -0.20 N/A 6,500.00%
Jun 30, 2022 -0.02 -0.21 N/A 9,047.62%
Mar 31, 2022 -0.47 -0.37 N/A -2,702.70%
Dec 31, 2021 -0.24 -0.30 N/A 2,000.00%
Sep 30, 2021 -0.11 -0.28 N/A 6,071.43%
Jun 30, 2021 -0.19 -0.34 N/A 4,411.76%
Mar 31, 2021 -0.47 -0.27 N/A -7,407.41%
Dec 31, 2020 -0.73 -0.27 N/A -17,037.04%
Sep 30, 2020 -0.24 -0.31 N/A 2,258.06%
Jun 30, 2020 -0.49 -0.38 N/A -2,894.74%
Mar 31, 2020 -0.30 -0.25 N/A -2,000.00%
Dec 31, 2019 -0.36 -0.25 N/A -4,400.00%
Sep 30, 2019 -0.18 -0.18 N/A 0.00%
Jun 30, 2019 -0.17 -0.08 N/A -11,250.00%
Mar 31, 2019 -0.21 -0.17 N/A -2,352.94%
Dec 31, 2018 -0.19 -0.19 N/A 0.00%
Sep 30, 2018 -0.15 -0.11 N/A -3,636.36%
Jun 30, 2018 -0.21 -0.14 N/A -5,000.00%
Mar 31, 2018 -0.24 -0.30 N/A 2,000.00%
Dec 31, 2017 -3.82 -0.17 N/A -214,705.88%
Sep 30, 2017 -1.70 -0.49 N/A -24,693.88%
Jun 30, 2017 -0.23 0.00 N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $43.82M $N/A $473.21M $118.64M $354.57M
2023-12-31 $31.06M $N/A $438.75M $61.72M $377.03M
2022-12-31 $8.99M $N/A $427.73M $49.08M $378.65M
2021-12-31 $9.01M $N/A $308.40M $83.03M $225.37M
2020-12-31 $30.13M $N/A $324.83M $90.06M $234.77M
2019-12-31 $70.78M $N/A $194.56M $52.20M $142.36M
2018-12-31 $60.69M $N/A $112.11M $30.37M $81.73M
2017-12-31 $42.58M $N/A $82.30M $34.81M $47.50M
2016-12-31 $1.61M $N/A $30.68M $24.68M $5.99M
2015-12-31 $3.88M $N/A $30.69M $19.38M $11.32M
2014-12-31 $6.58M $N/A $35.83M $17.85M $17.98M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist